3 must-reads on diabetes

Diabetic patients need extra patience, care, and a personalized approach. To support you in delivering the best possible care, dvm360 is committed to keeping readers informed about the latest advancements or treatment options available to veterinary professionals. To help, dvm360 is highlighting 3 articles that showcase tools available, research being conducted, and acquisitions of products.

Learn more in the articles below:

• Free diabetes management tools are now available to veterinary clinics: Veterinary clinics can gain access to free downloadable diabetes education materials and complimentary starter diabetes management kits for clients with diabetic pets by joining the Diabetes PetCare Alliance program, which is possible in collaboration with Merck Animal Health, ProPlan Veterinary Diets, and Zoetis.
• Human drug implant shows positive outcomes for feline obesity and diabetes management: (OKV-119; Vivani Medical),a long-term drug delivery system commonly used for chronic weight management in obese or overweight humans with one or more risk factors. This drug has been recently evaluated for use in cats to aid in managing feline obesity and diabetes.
• Global veterinary pharmaceutical specialist acquires innovative insulin programs: Dechra Limited acquired Akston Biosciences Corporation’s long-acting veterinary insulin programs. This acquisition provides Dechra—a global subsidiary of Dechra Pharmaceuticals Limited—with ownership of the intellectual property and rights to develop, manufacture, and commercially market the canine and feline insulin therapies globally.